๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy

โœ Scribed by Kato, Takanobu; Mizokami, Masashi; Orito, Etsuro; Ohba, Ken-ichi; Nakano, Tatsunori; Kondo, Yutaka; Tanaka, Yasuhito; Ueda, Ryuzo; Mukaide, Motokazu; Yasuda, Kiyomi; Iino, Shiro


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
137 KB
Volume
57
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

โœฆ Synopsis


GB virus C (GBV-C) is related to hepatitis C virus (HCV) and has a similar genomic structure. Some predictors for the efficacy of interferon (IFN) therapy on HCV have been reported: genotype, viral load, IFN dose, and the amino acid substitutions in the NS5A region, designated as the interferon sensitivity determining region (ISDR). To evaluate the correlation between the amino acid substitutions in the GBV-C NS5A region and the response to IFN therapy, singlestrand conformation polymorphism (SSCP) analysis was performed in the 12 concomitantly GBV-C-and HCV-infected patients who received IFN therapy at three time points: before, endpoint, and after the IFN therapy. The region in the GBV-C NS5A studied includes the amino acids that exhibit some homology to the ISDR and the various substitutions. By SSCP analysis, amplicons were separated into 1-4 bands, which indicated the existence of heterogeneity in each host. However, the deduced amino acid sequences in these bands exhibited no characteristic differences among these strains irrespective of response to IFN therapy. Of the 32 strains separated by SSCP, 7 strains were responders, and 25 were nonresponders. The mean amino acid substitution, compared with the consensus sequence of nonresponders, was 1.00 ยฑ 0.93 among responders, and 1.40 ยฑ 0.85 among nonresponders (P = NS). No correlation between the amino acid sequence in the GBV-C NS5A region and response to IFN therapy was found, indicating that the GBV-C NS5A region dose not act as the ISDR.


๐Ÿ“œ SIMILAR VOLUMES


Statistical analysis of combined substit
โœ Gary W. Witherell; Philip Beineke ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 216 KB ๐Ÿ‘ 2 views

Interferon (IFN) therapy (+/- ribavirin) is the only currently available treatment for chronic hepatitis C virus (HCV), but is not effective for a majority of patients. Several studies have correlated IFN response with substitutions in a small region of the nonstructural 5A (NS5A) gene product of HC

Fluctuations of hepatitis C virus load a
โœ Hashimoto, Michie; Chayama, Kazuaki; Kobayashi, Masahiro; Tsubota, Akihito; Aras ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 378 KB ๐Ÿ‘ 2 views

Hepatitis C virus (HCV) load is one of the most important predictive factors of response to interferon treatment. However, little is known about the mode and determinants of viremia. The mode of viremia was investigated in 78 patients with chronic HCV genotype 1b infection during 1-2 years follow up

Mutations in the nonstructural protein 5
โœ Komatsu, Haruki; Fujisawa, Tomoo; Inui, Ayano; Miyagawa, Yoshihiro; Onoue, Masah ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 38 KB ๐Ÿ‘ 2 views

A region associated with sensitivity to interferon (IFN) has been identified previously in the nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) genotype 1b. A study was undertaken to determine whether the presence of mutations in the NS5A 2209-2248 sequence could serve as a predictor of re

Selection of genetic variants of the 5?
โœ Lu, Mengji; Wiese, Manfred; Roggendorf, Michael ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 253 KB ๐Ÿ‘ 1 views

Interferon โฃ (IFN โฃ) can suppress the replication of hepatitis C virus (HCV) in chronically infected patients. However, HCV persists in a significant number of patients despite the normalization of alanine transaminase (ALT) during IFN โฃ therapy. In this study, HCV variants in patients under IFN โฃ t